A major pharmaceutical company that has invested heavily in North Carolina is planning multiple new factories in the U.S.

The Moor Bioenergy plant is set to supply 100 gigawatt hours of renewable energy annually to AstraZeneca's British operations ...

ZURICH (Reuters) - The investment vehicle of the Sandoz family will get 2.6 billion Swiss francs ($2.90 billion) from selling ...

With a market valuation of Rs 11,574.76 Cr, Sanofi Indias shares ended Fridays trading session on the BSE 0.58% higher at Rs ...

We can refer to full-year 2019 revenue of about $51 billion and the company's comments about potential revenue of more than ...

With Mayne Pharma subject to a $670 million takeover offer, investor attention turns to who might be acquired next.

Wegovy maker Novo Nordisk is accusing Mr Huang and his firm of fraudulent claims over a hypertension drug. Read more at ...

There is no escaping from the fact that the British company has proved perennially disappointing for investors. Around £10bn ...

Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells, as the pharma giant seeks to draw patients away from ...

Pharma company Ami Organics Ltd. saw its shares gain momentum today, with the stock rising by up to 3.7% in early trade.

Given the optimism around its obesity candidate, we believe investors should stay invested in Viking Therapeutics, regardless of buyout speculations.